GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Price-to-Owner-Earnings
中文

Novonesis AS (Novonesis AS) Price-to-Owner-Earnings

: 72.16 (As of Today)
View and export this data going back to 2009. Start your Free Trial

As of today (2024-04-23), Novonesis AS's share price is $55.56. Novonesis AS's Owner Earnings per Share (TTM) ended in Dec. 2023 was $0.77. It's Price-to-Owner-Earnings for today is 72.16.


The historical rank and industry rank for Novonesis AS's Price-to-Owner-Earnings or its related term are showing as below:

NVZMY' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 19.87   Med: 61.43   Max: 126.79
Current: 72.48

During the past 13 years, the highest Price-to-Owner-Earnings of Novonesis AS was 126.79. The lowest was 19.87. And the median was 61.43.


NVZMY's Price-to-Owner-Earnings is ranked worse than
84.86% of 720 companies
in the Chemicals industry
Industry Median: 19.15 vs NVZMY: 72.48

As of today (2024-04-23), Novonesis AS's share price is $55.56. Novonesis AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.57. Therefore, Novonesis AS's PE Ratio for today is 35.34.

As of today (2024-04-23), Novonesis AS's share price is $55.56. Novonesis AS's EPS without NRI for the trailing twelve months (TTM) ended in was $1.72. Therefore, Novonesis AS's PE Ratio without NRI for today is 32.23.

During the past 13 years, Novonesis AS's highest PE Ratio without NRI was 47.46. The lowest was 23.92. And the median was 32.02.


Novonesis AS Price-to-Owner-Earnings Historical Data

The historical data trend for Novonesis AS's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.81 47.96 105.22 53.68 68.63

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.68 70.96 72.73 60.92 68.63

Competitive Comparison

For the Specialty Chemicals subindustry, Novonesis AS's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS Price-to-Owner-Earnings Distribution

For the Chemicals industry and Basic Materials sector, Novonesis AS's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Price-to-Owner-Earnings falls into.



Novonesis AS Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Novonesis AS's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=55.56/0.77
=72.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS  (OTCPK:NVZMY) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Novonesis AS Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023

Not Just Yogurt Anymore

By PRNewswire 10-26-2023